ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 178 filers reported holding ARIAD PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $2,327,000 | -61.0% | 170,000 | -79.0% | 0.90% | -22.4% |
| Q2 2016 | $5,969,000 | +7.5% | 807,700 | -7.0% | 1.15% | +15.6% |
| Q1 2016 | $5,551,000 | +41.0% | 868,700 | +37.9% | 1.00% | +6.6% |
| Q4 2015 | $3,938,000 | +11.5% | 630,000 | +4.1% | 0.94% | +58.7% |
| Q3 2015 | $3,533,000 | -32.7% | 605,000 | -4.7% | 0.59% | -43.9% |
| Q2 2015 | $5,251,000 | +0.4% | 635,000 | 0.0% | 1.05% | -20.8% |
| Q1 2015 | $5,232,000 | +75.1% | 635,000 | +46.0% | 1.32% | +43.2% |
| Q4 2014 | $2,988,000 | +268.9% | 435,000 | +190.0% | 0.92% | +600.8% |
| Q3 2014 | $810,000 | – | 150,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $82,111,000 | 18.09% |
| Consonance Capital Management LP | 5,575,742 | $35,629,000 | 5.39% |
| Opaleye Management Inc. | 1,250,000 | $7,988,000 | 4.98% |
| Tamarack Advisers, LP | 1,600,000 | $10,224,000 | 3.58% |
| Camber Capital Management LP | 5,405,235 | $34,539,000 | 2.02% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 324,636 | $2,074,000 | 1.36% |
| Palo Alto Investors LP | 2,248,317 | $14,367,000 | 1.12% |
| 1492 Capital Management LLC | 202,500 | $1,294,000 | 1.09% |
| Geduld E E | 120,100 | $767,000 | 1.05% |
| JS Capital Management LLC | 868,700 | $5,551,000 | 1.00% |